Clinical & Experimental Allergy · 2009 · 51 citations · 33 references
Life SciencesImmunologyMolecular BiologyAllergyCellular ImmunologyHypersensitivityAllergen ImmunotherapyAllergen RecognitionAllergic DiseaseIge-mediated AllergyPollen AllergyType I HypersensitivityAllergen StructureCd4 Positive T Cell ResponsesHla Class Ii MoleculesIge-mediated ResponsesPollen Allergen CharacterizationPollen AllergensPollen ImmunotherapyT-cell Epitopes
BACKGROUND: Differences between major allergens from distinct grass species remain to be investigated, both in terms of structure and antigenicity. METHODS: Group 1 and 5 allergens purified from five common Pooideae species were analysed by mass spectrometry (MS). Major histocompatibility complex (MHC) class II-restricted T cell epitopes were identified using predictive algorithms and human leucocyte antigen (HLA)-binding assays. CD4+ T cell reactivity and IgE binding were assessed based on the induction of CD154 expression in peripheral blood mononuclear cells and using competitive ELISA assays, respectively. RESULTS: MS analysis of group 5 pollen allergens reveals considerable intra- and inter-species variability in amino acid sequence, with 30-50 predominant isoforms found for each species. Differences in the amino acid sequence as well as N- and O-glycosylation contribute to the variability of group 1 allergens, yielding 5-10 main isoforms, depending on the species. Out of 14 MHC class II-restricted T cell epitopes identified within group 1, only one is conserved among the five grass species. Significant differences in binding affinities for HLA-DR molecules result in variable CD4+ T cell recognition of group 1 and 5 allergens purified from the various species. Up to 38% and 85% of patients exhibit seric IgE responses to species-restricted (or semi-restricted) epitopes associated with group 1 or 5 allergens, respectively. CONCLUSION: Major pollen allergens from distinct grass species bear both shared and species-restricted T and B cell immune epitopes. When compared with single extracts, a five grass pollen extract is thus more suitable for specific immunotherapy, as it contains a broader repertoire of the IgE epitopes to which patients are sensitized.
33
Allergen-specific immunotherapy with recombinant grass pollen allergens
Marek Jutel, Lothar Jaeger, Roland Suck et al. · Journal of Allergy and Clinical Immunology · 2005 · 518 citations · Full text
Anthony J. Frew, Richard J. Powell, Christopher J. Corrigan et al. · Journal of Allergy and Clinical Immunology · 2006 · 373 citations · Full text